PATENT CLAIM ANALYSIS

Application Number: 15987277
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "210180"]

Abstract:
Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

Claim (Index 10):
A method of treating a disease or condition in a human subject which benefits from inhibition of p38 MAP kinase activity, said method comprising administering to a subject in need thereof and effective amount of a compound or pharmaceutically acceptable salt according to  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15388350', '14296730', '14895718', '14868516', '14296794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8209488499122716
- 35 USC 102 Novelty (BERT): 0.563548026953892
- Combined Prediction Score: 0.7952087676164336
- Mean Citation Score: 514.875808
- Max Citation Score: 525.1804
- Similarity Product: 298.8354137965202

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test